by editor | Dec 19, 2019 | Clinicians, Participants
A year of major achievements for long-term aspirin study This year, we welcomed a mid-year announcement that the NIA (National Institute on Aging) in the US would be funding the follow-up ASPREE-XT (eXTension) study for a further five years. Funding...
by editor | Aug 13, 2019 | Clinicians, Participants, Researchers
Impact of ASPREE trial on public health recognised We are pleased to share three Australian research accolades recently awarded to the ASPREE clinical trial for its significance to public health. ASPREE team acknowledged the contribution of participants,...
by editor | Aug 1, 2019 | Clinicians, Media, Participants, Researchers
Landmark study to assess long-term health risks and benefits of prior aspirin use in elderly PRESS RELEASE Landmark ASPREE study extended for five years to track study participants for long-term health outcomes after discontinuing aspirin. ASPREE-XT will...
by editor | Feb 20, 2019 | Clinicians, Participants, Researchers
A welcome to Melbourne Australian ASPREE investigators welcomed members from the National Cancer Institute (NCI) to the School of Public Health and Preventive Medicine, Monash University late last month. Pictured above: ASPREE investigators and researchers from...
by editor | Feb 14, 2019 | Clinicians, Researchers
The ASPREE Aftermath: A Geriatric Perspective on the Role of Aspirin in Older Adults Thanks to permission from the American College of Cardiology, we are pleased to share this physician-penned article on the importance of the ASPREE study and the...
Recent Comments